CREUTZFELDT-JAKOB DISEASE

Clinical trials for CREUTZFELDT-JAKOB DISEASE explained in plain language.

Never miss a new study

Get alerted when new CREUTZFELDT-JAKOB DISEASE trials appear

Sign up with your email to follow new studies for CREUTZFELDT-JAKOB DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Race against time: can an HIV drug slow a fatal brain disease?

Disease control Not yet recruiting

This study is testing whether a drug called efavirenz, currently used for HIV, can help people with Creutzfeldt-Jakob Disease (CJD) live longer. It will involve 246 adults with CJD across 21 hospitals. Half will receive the drug and half will receive a placebo (a dummy pill) to s…

Matched conditions: CREUTZFELDT-JAKOB DISEASE

Phase: PHASE3 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

CREUTZFELDT-JAKOB DISEASE

Get alerted when new CREUTZFELDT-JAKOB DISEASE trials appear

Race against time: can an HIV drug slow a fatal brain disease?